WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Stock Ownership - Who owns Cytomx Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytomx Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marcia BelvinSVP Chief Scientific Officer2025-06-1613,884$2.69
$37.33kSell
Christopher OgdenChief Financial Officer2025-06-1610,614$2.69
$28.54kSell
Sean A. McCarthyCEO2025-06-1655,511$2.69
$149.27kSell
Christopher OgdenChief Financial Officer2025-06-131,641$2.95
$4.84kSell
Marcia BelvinSVP Chief Scientific Officer2025-03-1819,512$0.60
$11.69kSell
Lloyd A. RowlandGeneral Counsel2025-03-1810,203$0.60
$6.11kSell
Yuwaye ChuChief Medical Officer2025-03-184,025$0.60
$2.41kSell
Sean A. McCarthyCEO2025-03-1837,656$0.60
$22.56kSell
Christopher OgdenChief Financial Officer2025-03-188,551$0.60
$5.12kSell

1 of 1

CTMX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTMX insiders and whales buy or sell their stock.

CTMX Shareholders

What type of owners hold Cytomx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vr Adviser LLC17.33%13,969,882$29.62MInstitution
Tang Capital Management LLC13.73%11,065,662$23.46MInstitution
Vanguard Group Inc11.63%9,379,794$19.89MInstitution
Fmr LLC11.46%9,238,868$19.59MInstitution
Orbimed Advisors LLC10.50%8,461,500$17.94MInstitution
Point72 Asset Management LP10.03%8,084,623$17.14MInstitution
Commodore Capital LP9.54%7,692,300$16.31MInstitution
Perceptive Advisors LLC8.67%6,993,646$14.83MInstitution
Franklin Resources Inc7.16%5,769,230$12.23MInstitution
Vivo Capital LLC7.16%5,769,230$12.23MInstitution

1 of 3

CTMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTMX85.98%14.02%Net SellingNet Selling
GLSI8.64%91.36%Net Buying
BDTX65.69%34.31%Net SellingNet Buying
KYTX50.85%49.15%
MOLN9.59%0.00%
View Top Biotech Stocks

Cytomx Therapeutics Stock Ownership FAQ

Who owns Cytomx Therapeutics?

Cytomx Therapeutics (NASDAQ: CTMX) is owned by 165.35% institutional shareholders, 26.97% Cytomx Therapeutics insiders, and 0.00% retail investors. Kevin P. Starr is the largest individual Cytomx Therapeutics shareholder, owning 5.20M shares representing 6.45% of the company. Kevin P. Starr's Cytomx Therapeutics shares are currently valued at $10.40M.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.